{"timestamp": 1771602921.8782718, "value": {"ticker": "VYNE", "company_name": "VYNE Therapeutics Inc.", "short_name": "VYNE Therapeutics Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 19968524, "float_shares": 32226781, "shares_outstanding": 33286422, "short_ratio": 0.95, "short_percent_of_float": 0.0165, "shares_short": 544777, "shares_short_prior": 1689232, "insider_percent_held": 0.043109998, "institution_percent_held": 0.26747, "total_cash": 32700000, "total_debt": 0, "total_revenue": 524000, "revenue_growth": 0.397, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -46.10651, "debt_to_equity": 0, "current_ratio": 8.874, "book_value": 1.01, "price_to_book": 0.5939604, "operating_cashflow": -38359000, "free_cashflow": -29259500, "price": 0.5999, "52w_high": 2.94, "52w_low": 0.281, "avg_volume": 5357953, "avg_volume_10d": 306140, "full_time_employees": 13, "audit_risk": 0, "overall_risk": 0}}